Article citationsMore>>

Wang, J., Dean, D.C., Hornicek, F.J., Shi, H. and Duan, Z. (2019) Cyclin-Dependent Kinase 9 (CDK9) Is a Novel Prognostic Marker and Therapeutic Target in Ovarian Cancer. The FASEB Journal, 33, 5990-6000.
https://doi.org/10.1096/fj.201801789RR

has been cited by the following article: